Montefiore Investment & Pléiade Investissement take majority stake in Generix Group
Context
Montefiore Investment has entered into exclusive negotiations to take Generix Group private through a public tender offer. The transaction is structured via a new acquisition holding company, New Gen, in partnership with the historical reference shareholder Pléiade Investissement (which has held a stake since 2002) and the company's management. The strategic rationale for the deal is to accelerate Generix's transition to a full SaaS model and drive its international expansion outside of its core French market. The transition will be accompanied by a leadership change, with Aïda Collette-Sène succeeding Jean-Charles Deconninck as head of the executive board. By delisting from Euronext (Compartment C), the company aims to pursue its long-term growth projects away from the short-term pressures of the public markets.
Generix Group, which reported an EBITDA margin of [members only] in 2021, is valued in this transaction at an EV/EBITDA multiple of 15x–25x.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Generix Group is a French software company specializing in collaborative supply chain and retail solutions. The organization provides a comprehensive suite of cloud-based services designed to optimize physical flows, digital processes, and customer experience for industrial players, logistics providers, and retailers. Its technology portfolio includes Warehouse Management Systems (WMS), Transport Management Systems (TMS), and EDI (Electronic Data Interchange) platforms. As of its 2021-2022 fiscal year, the entity generated 41% of its revenue through a SaaS subscription model, with the remainder coming from traditional licenses, maintenance, and consulting services. Headquartered in France, which accounts for over 55% of its turnover, the firm also maintains international operations, including a 7% revenue exposure to Russia. The group supports digital transformation by enabling seamless integration between supply chain actors and enhancing real-time data visibility across global distribution networks.
Ent. Value
€100–350M
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Montefiore Investment / Pléiade Investissement
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2026 | MONTEFIORE INVESTMENT / ACTIVA CAPITAL | ARCHE MC2 | FRANCE | Healthcare |
| 08/2025 | MONTEFIORE INVESTMENT / CERES INDUSTRIES CAPITAL / CFJ (COMPAGNIE FINANCIÈRE JOUSSET) | KARAVEL | FRANCE | Tour Operators |
| 10/2024 | MONTEFIORE INVESTMENT | DEMENEGO | ITALY | Ophthalmology |
| 10/2023 | MONTEFIORE INVESTMENT / BNP PARIBAS DEVELOPPEMENT / SOCIETE GENERALE CAPITAL PARTENAIRES / CARVEST (CRÉDIT AGRICOLE RÉGIONS INVESTISSEMENT) | KOESIO | FRANCE | MSP (Managed Services) |
| 05/2023 | MONTEFIORE INVESTMENT | EXO GROUP | ITALY | Finishing Works |
| 10/2021 | MONTEFIORE INVESTMENT | NGE | FRANCE | Public Works |
| 10/2020 | MONTEFIORE INVESTMENT | GROUPE OPEN | FRANCE | Consulting & Integration |
| 07/2016 | MONTEFIORE INVESTMENT | ISABEL MARANT | FRANCE | Fashion & Apparel |
| 11/2007 | MONTEFIORE INVESTMENT | ASMODEE GROUP | FRANCE | Consumer Products |
| 02/2006 | MONTEFIORE INVESTMENT | HOMAIR VACANCES | FRANCE | Hotels & Accommodation |
Similar deals in Software
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2022 | W.A.G PAYMENT SOLUTIONS | WEBEYE TELEMATICS | HUNGARY | Automotive |
| 05/2022 | CT ENGINEERING | INFODREAM | FRANCE | Supply Chain & Ops |
| 04/2022 | SOGELINK | FOCUS SOFTWARE | NORWAY | Engineering & Design Software |
| 04/2022 | SOGELINK | LOCATIQS | NETHERLANDS | Engineering & Design Software |
| 04/2022 | PATIENT SQUARE CAPITAL | SOC TELEMED | UNITED STATES | Healthcare |
| 04/2022 | VERVE | AXESINMOTION | SPAIN | Gaming & Consumer Apps |
| 03/2022 | CVC | RGI GROUP | ITALY | Financial Services / Banking |
| 03/2022 | ALBAREST / BPIFRANCE | MASA GROUP | FRANCE | Defense & Aerospace |
| 03/2022 | APAX PARTNERS | ALCUMUS | UNITED KINGDOM | Industry-Specific Software |
| 03/2022 | BPIFRANCE / EURAZEO | DOCTOLIB | FRANCE | Healthcare |
REFERENCES
Valuation range: EV €100–350M
Revenue range: €50–100M
EBITDA range: €5–25M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Generix Group by Montefiore Investment / Pléiade Investissement are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
FAQ
What transaction does this page cover?
How was the acquisition of Generix Group by Montefiore Investment valued, and what multiples were paid?
What were Generix Group’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?